Cargando…
A randomised controlled trial of potential for pharmacologic prevention of new-onset albuminuria, hypertension and diabetes in a remote Aboriginal Australian community, 2008–2013
INTRODUCTION: We conducted a double-blind randomised controlled trial in a remote-living Australian Aboriginal group at high risk for chronic disease to assess whether pharmacological treatment with angiotensin converting enzyme inhibitor (ACEi) could delay the onset of albuminuria, hypertension or...
Autores principales: | Hoy, Wendy E., Reid, Christopher M., Huq, Molla, McLeod, Beverly J., Mott, Susan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348198/ https://www.ncbi.nlm.nih.gov/pubmed/30705994 http://dx.doi.org/10.1016/j.conctc.2019.100323 |
Ejemplares similares
-
Transformation of mortality in a remote Australian Aboriginal community: a retrospective observational study
por: Hoy, Wendy E, et al.
Publicado: (2017) -
The predictive value of albuminuria for renal and nonrenal natural deaths over 14 years follow-up in a remote aboriginal community
por: Wang, Zaimin, et al.
Publicado: (2012) -
An expanded nationwide view of chronic kidney disease in Aboriginal Australians
por: Hoy, Wendy E, et al.
Publicado: (2016) -
Familial aggregation of albuminuria and arterial hypertension in an Aboriginal Australian community and the contribution of variants in ACE and TP53
por: Duffy, David L., et al.
Publicado: (2016) -
Prediction of cardiovascular disease risk using waist circumference among Aboriginals in a remote Australian community
por: Adegbija, Odewumi, et al.
Publicado: (2015)